Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment
Recruiting
N/A
Interventional Study
Peptic Ulcer Bleeding
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 162 (estimated)
- Sponsor
- Mario Steffanus · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare the effects of tegoprazan vs lansoprazole in healing bleeding peptic ulcers. It will also teach about the safety of both modalities. The main questions it aims to answer are:
How does the effectiveness of Tegoprazan compare with Lansoprazole in two weeks of healing rate bleeding peptic ulcer patients in the Indonesian population?
Researchers will com…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects diagnosed with upper gastrointestinal bleeding caused by peptic ulcer through gastroscopic examination
Exclusion Criteria:
* Allergic to Tegoprazan or Lansoprazole
* Diagnosed with gastric or duodenal cancer, pregnant
* History of H. pylori infection treatment failu…
Contacts